Recombinant Mouse VSTM2B Protein, N-His-SUMO

Description of Recombinant Mouse VSTM2B Protein, N-His-SUMO

Structure of Recombinant Mouse VSTM2B Protein

Recombinant Mouse VSTM2B Protein is a type I transmembrane protein that is encoded by the V-set and transmembrane domain-containing 2B (VSTM2B) gene. It is a member of the immunoglobulin superfamily and is highly conserved across species, with a 92% amino acid sequence identity between mouse and human VSTM2B.

The protein has a predicted molecular weight of 26 kDa and consists of 230 amino acids. It contains a signal peptide at the N-terminus, followed by a V-set immunoglobulin domain, a transmembrane domain, and a short cytoplasmic tail. The V-set domain is responsible for the protein’s antigen-binding activity, while the transmembrane domain anchors it to the cell membrane.

Activity of Recombinant Mouse VSTM2B Protein

Recombinant Mouse VSTM2B Protein is a cell surface protein that has been shown to have a role in immune regulation. It is expressed on various immune cells, including B cells, T cells, and dendritic cells, and has been found to interact with other immune-related proteins such as CD200 receptor and CD200 ligand.

One of the main functions of VSTM2B is to regulate the activation and differentiation of immune cells. It has been reported that VSTM2B-deficient mice exhibit enhanced T cell proliferation and cytokine production, suggesting a suppressive role of VSTM2B in T cell activation. In addition, VSTM2B has been shown to modulate B cell activation and antibody production.

VSTM2B has also been implicated in the regulation of immune tolerance. It has been reported that VSTM2B-deficient mice develop spontaneous autoimmune diseases, including systemic lupus erythematosus and inflammatory arthritis. This suggests that VSTM2B plays a critical role in maintaining immune tolerance and preventing autoimmunity.

Application of Recombinant Mouse VSTM2B Protein

Recombinant Mouse VSTM2B Protein has a wide range of applications in both basic research and clinical settings. Its role in immune regulation makes it a valuable tool for studying the immune system and its dysregulation in various diseases.

One of the main applications of recombinant VSTM2B protein is in the development of immunotherapies for autoimmune diseases. By targeting VSTM2B, researchers aim to modulate the immune response and restore immune tolerance in patients with autoimmune disorders.

In addition, recombinant VSTM2B protein can also be used as a diagnostic tool for autoimmune diseases. The detection of VSTM2B autoantibodies in patient sera has been reported in several autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. This suggests that VSTM2B autoantibodies could serve as potential biomarkers for these diseases.

Furthermore, recombinant VSTM2B protein has potential applications in cancer research. Recent studies have shown that VSTM2B is upregulated in various types of cancer, including breast, lung, and pancreatic cancer. It has been proposed that VSTM2B may play a role in tumor immune evasion and could serve as a potential therapeutic target for cancer treatment.

In conclusion, recombinant Mouse VSTM2B Protein is a highly conserved transmembrane protein that plays a critical role in immune regulation. Its structure, activity, and various applications make it a valuable tool for studying the immune system and its dysregulation in diseases such as autoimmune disorders and cancer. Further research on this protein could lead to the development of novel immunotherapies and diagnostic tools for various diseases.